-
3 Oncology Generics, Branded Generics and Biologics Platform Stocks With a Strong Future Roadmap: Natco Pharma, Emcure Pharmaceuticals and Shilpa Medicare
- October 21, 2026
- Posted by: Kunal Singla
- Category: Best Stocks
No Comments
Specialty Generics and Oncology Stocks with a strong future roadmap: Natco Pharma, Emcure Pharmaceuticals and Shilpa Medicare. Compare price, valuation, return on equity and revenue growth as of 20 October 2026.
-
3 Global Generics, Branded Generics and Contract Formulations Stocks With a Strong Future Roadmap: Aurobindo Pharma, Emcure Pharmaceuticals and Innova Captab
- October 21, 2026
- Posted by: Chaitanya Auti
- Category: Best Stocks
Generic and Branded Pharma Stocks with a strong future roadmap: Aurobindo Pharma, Emcure Pharmaceuticals and Innova Captab. Compare price, valuation, return on equity and revenue growth as of 20 October 2026.
-
3 Hospital Pharma, Generic Formulations and Domestic Brands Stocks With a Strong Future Roadmap: Emcure Pharmaceuticals, Strides Pharma Science and Mankind Pharma
- October 21, 2026
- Posted by: Neeraj Pandey
- Category: Best Stocks
Formulation Pharma Stocks with a strong future roadmap: Emcure Pharmaceuticals, Strides Pharma Science and Mankind Pharma. Compare price, valuation, return on equity and revenue growth as of 20 October 2026.